# Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects

> **NCT06025552** · PHASE1 · COMPLETED · sponsor: **TiumBio Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Hemophilia a
- Hemophilia B
- Blood Coagulation Disorders

## Interventions

- **DRUG:** TU7710
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT06025552
- **Lead sponsor:** TiumBio Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-02
- **Primary completion:** 2024-08-21
- **Final completion:** 2024-08-21
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025552, "Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06025552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*